Zooming in on COVID-19 and Other Viral Diseases Symposim, Day 2

Day 2 Features

  • Sessions 2 and 3 showcase research on vaccines and antivirals
  • Career networking session for trainees with leading experts
  • Opportunity to engage with poster presenters
  • Evening social event

Wednesday, June 23, 2021 

Day 2 Schedule

9 – 10:50 a.m.

Session 2 - Vaccines and Diagnostics

Session Moderator: Matthias GötteUniversity of Alberta
Keynote seminar: Derrick RossiConvelo Therapeutics, Inc.
Stem cell science and the genesis of new therapeutic strategies for patients

Research Talks:

  • Galit Alter, Ragon Institute of MGH, MIT, and Harvard
    Systems serology to define correlates of immunity to SARS-CoV-2
  • Darryl Falzarano, University of Saskatchewan
    Development of COVAC-1: a S1 subunit SARS-CoV-2 vaccine that prevents upper respiratory tract shedding in multiple animal models
  • Graham Tipples, Precision Laboratories, Alberta Health Services
    Lab diagnostics and surveillance for COVID in Alberta

Elevator Pitches selected from abstracts (3 speakers)

10:50 –  11 a.m.


11 – 12:50 p.m.

Session 3 - Antivirals

Session Moderator: David EvansUniversity of Alberta
Keynote seminar: Matthias Götte, University of Alberta
Targeting the replication transcription complex of emerging viruses with broad spectrum antivirals

Research Talks:

  • M. Joanne Lemieux, University of Alberta
    Towards development of an oral protease inhibitor to treat SARS-CoV-2 infection
  • Andrés Finzi, Université de Montréal
    SARS-CoV-2: beyond viral neutralization
  • Tom Hobman, University of Alberta
    Host cell targets for antiviral therapy

Elevator Pitches selected from abstracts (3 speakers)

12:50 – 1 p.m.


1 – 2 p.m.

Career Networking Session #2

2 – 2:30 p.m.

Poster Q&A Session #2 Via Chat

Selected from abstracts

6 p.m.

Social Event

Day 1 Schedule